ESPR icon

Esperion Therapeutics

136 hedge funds and large institutions have $352M invested in Esperion Therapeutics in 2022 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 42 increasing their positions, 42 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

5.14% more ownership

Funds ownership: 82.66%87.8% (+5.1%)

3% more funds holding

Funds holding: 132136 (+4)

0% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 42

Holders
136
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$14.4M
Puts
$2.78M
Net Calls
Net Calls Change

Top Buyers

1 +$13.1M
2 +$9.27M
3 +$6.76M
4
WP
Woodline Partners
California
+$5.37M
5
BlackRock
BlackRock
New York
+$3.37M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$140K
77
$131K
78
$126K
79
$118K
80
$116K
81
$114K
82
$113K
83
$108K
84
$107K
85
$104K
86
$85K
87
$82K
88
$79K
89
$78K
90
$76K
91
$76K
92
$70K
93
$69K
94
$66K
95
$65K
96
$65K
97
$65K
98
$64K
99
$63K
100
$55K